ETView Medical, Ltd. Announces SFDA Clearance of a Pre-Marketing Notification Application for the VivaSight-SL Line of Innovative Airway Devices
3/18/2013 10:49:40 AM
TEL AVIV, Israel--(BUSINESS WIRE)--ETView (TASE: ETVW) today announced that the company has received clearance of a Pre-Marketing Notification Application with the State Food and Drug Administration (SFDA, China). The Company expects to enter the Chinese market with the VivaSight-SL immediately. VivaSight-SL will be exclusively distributed throughout China by the China National Pharmaceutical Group Corporation, SINOPHARM. Additional pre-market regulatory clearances world-wide are anticipated during 2013.
comments powered by